Considering all RA in the cohort, 56.8% and 10.9% of patients were immunopositive for ACa-Fib IgG in anti-CCP-positive and anti-CCP-negative patients respectively (Figure 4A). The gene discussed is FBL; the disease is rheumatoid arthritis.